drug maker

Drug maker seeks to block competitor’s inversion

17/09/2014(0)

Pharmaceutical company, Endo International, which struck an inversion last year and reincorporated in Ireland, tries to stop an inversion by Auxilium Pharmaceutical, a smaller rival. Endo made on Tuesday ... Read More

AstraZeneca rejects the bid from Pfizer

02/05/2014(0)

The board of pharmaceutical company AstraZeneca on Friday flatly rejected drug maker Pfizer’s sweetened takeover offer just hours after it was levelled, describing it as inadequate. Pfizer Inc., the ... Read More

Top benefits of self-paced online learning

In modern training development, self-paced online learning is quickly becoming… more>>
ESMA presents methodology for climate risk stress testing and analysis of the financial impact of greenwashing controversies

The European Securities and Markets Authority (ESMA), the EU’s financial… more>>
Global crypto user base surpassed half a billion in 2023 — Crypto.com report

A research report from Crypto.com estimates the number of worldwide… more>>

Permission is hereby granted for the personal, non-commercial downloading, printing, transmission and temporary storage of any materials on this web site. All other use of the materials, in whole or in part (including without limitation reproduction, permanent storage, re-distribution and incorporation into other materials or web pages) is prohibited without the prior written consent of GP ONESTOPBROKER.

Every item and in general the content of the Website may be amended, completed, deleted or updated at any time without notice at GP ONESTOPBROKER’s absolute discretion. Read More

Risk Warning: Trading financial instrument involves high risks. Before start trading you should be aware of all the risks associated and the possibility of loss of your invested capital. Information contained in this website is not necessarily real-time or accurate. Read More

Legal Disclaimer: onestopbrokers.com is operated by GP ONESTOPBROKER, a registered trade name of GP Global Ltd.

Privacy Policy: Privacy Policy is updated on 24/05/2018 Read More

Cookies Policy: We use cookies to improve your browsing experience on our site, show personalized content and targeted ads, analyze site traffic, and understand where our audience is coming from. By continuing to navigate our website without changing your cookies settings you hereby acknowledge and agree to the use of cookies. Read More

Terms and Conditions | Privacy Policy | Risk Warning

drug maker

Drug maker seeks to block competitor’s inversion

AstraZeneca rejects the bid from Pfizer

OSB – Daily Cheat Sheet

Articles

Find a Job

Share your Opinion – Poll

Interviews

Popular Posts

Latest News

Top benefits of self-paced online learning

ESMA presents methodology for climate risk stress testing and analysis of the financial impact of greenwashing controversies

Global crypto user base surpassed half a billion in 2023 — Crypto.com report

Subscribe